Our customers' Feedback
Search:
Perform search
Categories list

Generic Zidovudine - Combivir, Retrovir

News & Dashboard
Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Combivir
Generic Combivir is in a group of medicines called reverse transcriptase inhibitors. It is used for treating HIV infection in combination with other medicines.
$1.44
Retrovir
Generic Retrovir is used for treating HIV infection when used along with other medicines. It is also used with other medicines to help prevent women from passing the HIV virus to the fetus during pregnancy.
$1.17
Social bookmarks:
Choose your language:
United Kingdom - EN/£France - FR/€Deutschland - DE/€España - ES/€Italia - IT/€Portugal - PT/€European Union - EN/€México - ES/$Brasil - PT/$Canada - FR/$




Money backguarantee
Secureshopping

Our billing is certified by:

Secure shopping certificates

Special Offer!

  • HHS Releases Updated Guidelines For Treatment Of HIV-Positive Children And Teens - The AIDS Beacon (blog)

    HHS Releases Updated Guidelines For Treatment Of HIV-Positive Children And TeensThe AIDS Beacon (blog)Drugs that should not be combined in children include Epivir (lamivudine) plus Emtriva (emtricitabine), zidovudine (Retrovir) plus stavudine (Zerit), .

  • Promising outcomes of a national programme for the prevention of mother-to ... - 7thSpace Interactive (press release)

    Promising outcomes of a national programme for the prevention of mother-to .

  • AIDS Conference: Encouraging Advances Amid Funding Worries for Global Treatment - Journal of American Medical Association (subscription)

    AIDS Conference: Encouraging Advances Amid Funding Worries for Global TreatmentJournal of American Medical Association (subscription).

  • Gilead Sciences Submits European Marketing Application for Once-Daily Single ... - MarketWatch (press release)

    Gilead Sciences Submits European Marketing Application for Once-Daily Single .

  • Gilead Sciences Submits European Marketing Application For Once-Daily Single ... - Medical News Today (press release)

    Gilead Sciences Submits European Marketing Application For Once-Daily Single .

    Copyright © www.secure-pharm.com. All rights reserved.